Centessa Pharmaceuticals plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 216.21 million compared to USD 381.9 million a year ago. Basic loss per share from continuing operations was USD 2.31 compared to USD 5.07 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 USD | -4.00% | -6.03% | +5.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.65% | 977M | |
+64.83% | 62.59B | |
-2.04% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.98% | 26.21B | |
-21.88% | 19.09B | |
+3.97% | 13.08B | |
+25.46% | 12.26B | |
+27.32% | 12.05B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2022